Elisa Houwink MD MD, PhD (She/Her)
Preventive Medicine, Women's Health, Healthcare Research and Healthcare Policy
Associate Professor Genetics and Pharmacogenetics in Primary Care Practice
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Houwink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elisa Houwink is a family physician in Rochester, MN, affiliated with Mayo Clinic Hospital - Rochester. She received her medical degree from Maastricht University, The Netherlands, and received her PhD in "Training in genetics and genomics for primary health care workers" (https://research.vu.nl/en/publications/training-in-genetics-and-genomics-for-primary-health-care-workers) and has been in practice 20 years. She specializes in preventive medicine, women's health, and healthcare research and healthcare policy. Besides working as a family medical doctor, Dr. Isa Houwink is an associate professor of family medicine (50/50). Her research and educational involvement include prevention, screening, and early detection modalities in common and rare diseases and implementing pharmacogenetics in primary care practice. She has 55 publications, 2060 citations, and an h-index of 21 (https://www.researchgate.net/profile/Isa-Houwink/research)
Education & Training
Mayo Clinic College of MedicineClass of 2003
Certifications & Licensure
MN State Medical License 2022 - 2025
American Board of Family Medicine Family Medicine
Clinical Trials
- Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: Start of enrollment: 2024 Dec 01
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsDutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas.David F G J Wolthuis, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne Marie Buunk
European Journal of Human Genetics. 2024-12-15 - Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants.Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk
European Journal of Human Genetics. 2024-11-01 - 5 citationsDutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.Lisanne E N Manson, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk
European Journal of Human Genetics. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
